23
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Mating Enhances Expression of Hormonal and Trophic Factors in the Midbrain of Female Rats

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Among female rats, mating enhances neurosteroid formation in the midbrain ventral tegmental area (VTA; independent of peripheral steroid-secreting glands, ovaries, and adrenals). The sources/targets for these actions are not well understood. In Experiment 1, proestrous rats engaged in a mating paradigm, or did not, and the midbrains had been assessed via the Affymetrix rat genome microarrays. In Experiment 2, the influence of gonadal and adrenal glands on the expression of these genes was assessed in rats that were proestrous, ovariectomized (OVX), or OVX and adrenalectomized (ADX). The microarrays revealed 53 target genes that were significantly up-regulated (>2.0-fold change) in response to mating. Mating significantly enhanced the midbrain mRNA expression of genes involved in hormonal and trophic actions: Gh1, S100g, and Klk1b3 in proestrous, but not OVX and/or ADX, rats; Fshb in all but OVX/ADX rats; and lutenizing hormone β and thyroid-stimulating hormone (TSH) β in all rats. Thus, mating enhances midbrain gene expression independent and dependent of peripheral glands.

          Related collections

          Most cited references92

          • Record: found
          • Abstract: not found
          • Article: not found

          Sexual attractivity, proceptivity, and receptivity in female mammals.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Neuroactive steroids.

            S Paul, R Purdy (1992)
            Neuroactive steroids are natural or synthetic steroids that rapidly alter the excitability of neurons by binding to membrane-bound receptors such as those for inhibitory and (or) excitatory neurotransmitters. The best-studied neuroactive steroids are a series of sedative-hypnotic 3 alpha-hydroxy ring A-reduced pregnane steroids that include the major metabolites of progesterone and deoxycorticosterone, 3 alpha-hydroxy-5 alpha-pregnan-20-one (allopregnanolone) and 3 alpha,21-dihydroxy-5 alpha-pregnan-20-one (allotetrahydroDOC), respectively. These 3 alpha-hydroxysteroids do not interact with classical intracellular steroid receptors but bind stereoselectively and with high affinity to receptors for the major inhibitory neurotransmitter in brain, gamma-amino-butyric acid (GABA). Biochemical and electrophysiological studies have shown that these steroids markedly augment GABA-activated chloride ion currents in a manner similar (but not identical) to that of anesthetic barbiturates. Several steroids have also been observed to have convulsant or proconvulsant properties, including the synthetic amidine 3 alpha-hydroxy-16-imino-5 beta-17-azaandrostan-11-one (RU5135) and the natural sulfate esters of pregnenolone and dehydroepiandrosterone. Several of these have been shown to be bicuculline or picrotoxin-like GABAA receptor antagonists. Examples of steroids that alter neuronal excitability rapidly by augmenting or inhibiting excitatory amino acid receptor-mediated responses have also been reported. Recently, allopregnanolone and allotetrahydroDOC have also been measured in brain and plasma where their levels have been shown to fluctuate in response to stress and during the estrous and menstrual cycles of rats and humans, respectively. Although the major fraction of allopregnanolone in tissue, including brain, is of adrenal and/or ovarian origin, appreciable levels of allopregnanolone can still be measured in the brains of adrenalectomized and/or oophorectomized animals. Receptor-active neurosteroids may represent an important class of neuromodulators that can rapidly alter central nervous system excitability via novel nongenomic mechanisms.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The lutropin/choriogonadotropin receptor, a 2002 perspective.

              Reproduction cannot take place without the proper functioning of the lutropin/choriogonadotropin receptor (LHR). When the LHR does not work properly, ovulation does not occur in females and Leydig cells do not develop normally in the male. Also, because the LHR is essential for sustaining the elevated levels of progesterone needed to maintain pregnancy during the first trimester, disruptions in the functions of the LHR during pregnancy have catastrophic consequences. As such, a full understanding of the biology of the LHR is essential to the survival of our species. In this review we summarize our current knowledge of the structure, functions, and regulation of this important receptor.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Behav Neurosci
                Front Behav Neurosci
                Front. Behav. Neurosci.
                Frontiers in Behavioral Neuroscience
                Frontiers Media S.A.
                1662-5153
                15 April 2020
                2020
                : 14
                : 21
                Affiliations
                [1] 1Department of Psychology, The University at Albany-SUNY , Albany, NY, United States
                [2] 2Department of Biological Sciences, The University at Albany-SUNY , Albany, NY, United States
                [3] 3Center for Neuroscience Research, The University at Albany-SUNY , Albany, NY, United States
                [4] 4Center for Life Sciences Research, The University at Albany-SUNY , Albany, NY, United States
                [5] 5Center for Functional Genomics, The University at Albany-SUNY , Albany, NY, United States
                Author notes

                Edited by: Liana Fattore, Italian National Research Council, Italy

                Reviewed by: Elaine M. Hull, Florida State University, United States; Jonathan Eloy Martinez, University of Valparaíso, Chile; Marianna Tyczewska, Poznan University of Medical Sciences, Poland

                *Correspondence: Cheryl A. Frye cherylafrye@ 123456gmail.com

                Specialty section: This article was submitted to Behavioral Endocrinology, a section of the journal Frontiers in Behavioral Neuroscience

                Article
                10.3389/fnbeh.2020.00021
                7176275
                9e17059f-f296-44a7-88d7-4929247e3d11
                Copyright © 2020 Frye and Chittur.

                This is an open-access article distributed under the terms of theCreative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 20 October 2019
                : 31 January 2020
                Page count
                Figures: 2, Tables: 3, Equations: 0, References: 93, Pages: 13, Words: 10448
                Funding
                Funded by: National Institute of Mental Health 10.13039/100000025
                Categories
                Behavioral Neuroscience
                Original Research

                Neurosciences
                calbindin,follicle-stimulating hormone,growth hormone,kallikrekin peptidase,luteinizing hormone,thyroid-stimulating hormone

                Comments

                Comment on this article